Monday, December 23, 2024
HomeTagsAVA6000

AVA6000

Avacta Announces AVA6000 Receives Orphan Drug Designation From the US FDA

Avacta Group plc, a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer and pre|CISION™ platforms, announces that...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics